Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013
Asim Malik, Karim Medhat El Masry, Mini Ravi, F Abdelwahab Sayed
Abstract
Open-access reader
Asim Malik, Karim Medhat El Masry, Mini Ravi, F Abdelwahab Sayed
Abstract
Open-access reader
As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin-peginterferon-α therapy.
OpenAlex reports 91 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin-peginterferon-α therapy.
Key concepts: Middle East respiratory syndrome coronavirus, Abu dhabi, Middle East respiratory syndrome, Pregnancy, Coronavirus disease 2019 (COVID-19), Medicine, Pandemic, 2019-20 coronavirus outbreak